Latest Articles

Vice President Biden Calls for Greater Urgency at Cancer Moonshot Summit
BY KATIE HAY
At the Cancer Moonshot Summit, the vice president announced several new initiatives that support the program’s goals of speeding up cancer research.
Niraparib Improves Outcomes for Patients With Ovarian Cancer
BY SILAS INMAN
Maintenance treatment with the novel agent niraparib improved progression-free survival (PFS) compared with placebo for patients with recurrent ovarian cancer harboring a germline BRCA (gBRCA) mutation or homologous recombination deficiency (HRD).
On Twitter, MPN Patients and Physicians Connect in Real Time
BY ANDREW J. ROTH
CURE recently interviewed Naveen Pemmaraju to discuss the unique aspects of the MPN community, the pitfalls of social media and the importance of patients and physicians interacting.
Discussing Cancer Symptom Management With Nurse Darcy Burbage
BY CURE STAFF
Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends.
CRISPR Gene Editing Technology Moves Forward, NIH Panel Approves Human Trial
BY ANITA T. SHAFFER
Scientists are enthusiastic about new technology that will be able to edit human genes. 
Expert Reviews Importance of BRCA Testing in Ovarian Cancer
BY GREG KENNELTY
Testing for BRCA mutations is an important step in developing the treatment plan for patients with breast cancer, says Leslie Randall. 
Jakafi Continues to Progress in Treatment of Acute Graft-Versus-Host Disease
BY JASON M. BRODERICK
Two studies showed that Jakafi has high response rates with patients with GVHD, making the FDA give the drug a breakthrough therapy designation. 
My Oncology Nurse and Lifesaver
BY MALLORY TURCHI
An Extraordinary Healer essay honoring Nancy Dodds, RN, ONC [ Hurley Medical Center in Flint, Michigan ]
Just an Oncology Nurse? Not At All
BY NINA GARKAVI
An Extraordinary Healer essay honoring Corrine C. Hoeppner, MN, ARNP [Seattle Children's Hospital in Seattle, Washington]
$auto_registration$